Keystone Financial Planning, Inc. Pfizer Inc Transaction History

Keystone Financial Planning, Inc.

$323 Million
Q1 2025

A detailed history of Keystone Financial Planning, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Keystone Financial Planning, Inc. holds 256,187 shares of PFE stock, worth $5.98 Million. This represents 2.01% of its overall portfolio holdings.

Number of Shares

256,187

Previous 256,187 -0.0%

Holding current value

$5.98 Million

Previous $6.8 Million 4.49%

% of portfolio

2.01%

Previous 2.17%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 13, 2025	SELL	$24.8 - $30.19 $12,697 - $15,457	-512 Reduced 0.2%	256,187 $6.8 Million
Q3 2024 Oct 28, 2024	SELL	$27.7 - $31.39 $5,844 - $6,623	-211 Reduced 0.08%	256,699 $7.43 Million
Q2 2024 Jul 10, 2024	SELL	$25.26 - $29.6 $6,693 - $7,844	-265 Reduced 0.1%	256,910 $7.19 Million
Q1 2024 Apr 10, 2024	SELL	$25.89 - $29.73 $213,281 - $244,915	-8,238 Reduced 3.1%	257,175 $7.14 Million
Q4 2023 Jan 12, 2024	BUY	$26.13 - $33.94 $510,501 - $663,085	19,537 Added 7.95%	265,413 $7.64 Million
Q3 2023 Oct 10, 2023	BUY	$32.09 - $37.51 $437,386 - $511,261	13,630 Added 5.87%	245,876 $8.16 Million
Q2 2023 Jul 11, 2023	BUY	$36.12 - $41.79 $514,023 - $594,713	14,231 Added 6.53%	232,246 $8.52 Million
Q1 2023 Apr 21, 2023	BUY	$39.39 - $51.28 $6.4 Million - $8.33 Million	162,376 Added 291.84%	218,015 $8.9 Million
Q4 2022 Jan 30, 2023	SELL	$41.75 - $54.5 $13,067 - $17,058	-313 Reduced 0.56%	55,639 $2.85 Million
Q3 2022 Oct 12, 2022	SELL	$43.76 - $53.42 $354,368 - $432,595	-8,098 Reduced 12.64%	55,952 $2.45 Million
Q2 2022 Jul 19, 2022	BUY	$46.53 - $55.17 $397,971 - $471,869	8,553 Added 15.41%	64,050 $3.36 Million
Q1 2022 Apr 28, 2022	BUY	$45.75 - $56.69 $24,293 - $30,102	531 Added 0.97%	55,497 $2.87 Million
Q4 2021 Feb 09, 2022	SELL	$41.32 - $61.25 $7.3 Million - $10.8 Million	-176,640 Reduced 76.27%	54,966 $3.25 Million
Q3 2021 Oct 15, 2021	SELL	$39.25 - $50.42 $226,865 - $291,427	-5,780 Reduced 2.43%	231,606 $9.96 Million
Q2 2021 Aug 13, 2021	SELL	$35.91 - $40.68 $112,901 - $127,897	-3,144 Reduced 1.31%	237,386 $9.3 Million
Q1 2021 May 07, 2021	BUY	$33.49 - $37.77 $174,918 - $197,272	5,223 Added 2.22%	240,530 $8.71 Million
Q4 2020 Feb 04, 2021	BUY	$33.47 - $42.56 $228,499 - $290,557	6,827 Added 2.99%	235,307 $8.66 Million
Q3 2020 Nov 05, 2020	BUY	$31.75 - $37.25 $60,166 - $70,588	1,895 Added 0.84%	228,480 $8.39 Million
Q2 2020 Jul 27, 2020	BUY	$30.12 - $36.54 $96,865 - $117,512	3,216 Added 1.44%	226,585 $7.41 Million
Q1 2020 May 05, 2020	BUY	$27.03 - $38.62 $242,378 - $346,305	8,967 Added 4.18%	223,369 $7.29 Million
Q4 2019 Feb 06, 2020	BUY	$32.92 - $37.36 $228,826 - $259,689	6,951 Added 3.35%	214,402 $8.4 Million
Q3 2019 Oct 08, 2019	BUY	$32.49 - $42.13 $256,118 - $332,110	7,883 Added 3.95%	207,451 $7.45 Million
Q2 2019 Aug 05, 2019	SELL	$36.98 - $41.52 $11,500 - $12,912	-311 Reduced 0.16%	199,568 $8.65 Million
Q1 2019 May 15, 2019	BUY	$37.5 - $41.2 $58,012 - $63,736	1,547 Added 0.78%	199,879 $8.49 Million
Q4 2018 Feb 05, 2019	BUY	$38.47 - $43.86 $22,004 - $25,087	572 Added 0.29%	198,332 $8.66 Million
Q3 2018 Nov 02, 2018	SELL	$34.47 - $41.81 $181,622 - $220,296	-5,269 Reduced 2.6%	197,760 $8.72 Million
Q2 2018 Aug 06, 2018	BUY	$32.98 - $35.16 $45,479 - $48,485	1,379 Added 0.68%	203,029 $7.37 Million
Q1 2018 May 01, 2018	BUY	$31.91 - $37.02 $205,308 - $238,186	6,434 Added 3.3%	201,650 $7.16 Million
Q4 2017 Feb 07, 2018	BUY	$33.26 - $35.29 $74,502 - $79,049	2,240 Added 1.16%	195,216 $7.07 Million
Q3 2017 Nov 08, 2017	BUY	$31.0 - $34.15 $5.98 Million - $6.59 Million	192,976	192,976 $6.89 Million

Others Institutions Holding PFE

# of Institutions

3,369

Shares Held

3.61B

Call Options Held

102M

Put Options Held

130M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $131B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Keystone Financial Planning, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Keystone Financial Planning, Inc. with notifications on news.

Account

Keystone Financial Planning, Inc. Pfizer Inc Transaction History